BANK OF AMERICA CORP /DE/
BankPosition in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,883,515
+$23,873,858 QoQ
Shares Held
1,333,071
+86.2% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 264 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CRNX ranks #48 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,883,515 | 1,333,071 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $26,009,657 | 716,125 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $37,301,163 | 801,314 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $25,033,396 | 601,042 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $16,487,587 | 573,282 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,227,216 | 304,926 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,029,915 | 235,281 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,209,527 | 278,073 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,668,517 | 305,169 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,717,815 | 357,142 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,254,213 | 344,413 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,606,724 | 154,900 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,169,138 | 120,374 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,834,156 | 176,473 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,270,425 | 124,067 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,167,734 | 59,457 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,012,433 | 54,286 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,149,649 | 97,934 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,934,634 | 68,097 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $244,642 | 11,622 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $247,104 | 13,109 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $188,249 | 12,320 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $272,604 | 19,320 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $318,413 | 20,320 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $365,011 | 20,834 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $138,708 | 9,436 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||